Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-03
2007-07-03
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S212070, C514S217120, C514S220000, C514S221000, C514S307000, C540S504000, C540S552000, C540S562000, C540S563000, C540S566000, C540S573000, C540S593000, C546S144000
Reexamination Certificate
active
10486602
ABSTRACT:
The invention relates to novel benzo-fused heterocycles and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as endothelin receptor antagonists.
REFERENCES:
Kocienski, P.J., “Protecting Groups,” 1994, New York, Table of Contents.
March, J., “Advanced Organic Chemistry,” 1984, New York, Table of Contents.
Romeo, G., et al., “Nuclear Magnetic Resonance of Psychotherapeutic Agents,” Organic Magnetic Resonance, vol. 15, No. 1, 1981, pp. 33-36.
Hiroshi, A., et al., “Cloning and expression of a cDNA encoding an endothelin receptor,” Nature, vol. 348, Dec. 1990.
Effland, R.C., et al., Synthesis of 1,4-Benzodiazepino[4,5-d][1,4]benzoxazepines, May-Jun. 1982, pp. 537-539.
Walser, A., et al., Quinazolines and 1,4-Benzodiazepines, XC111. (1). Synthesis of Imidazo[1,5-a][1,4]benzodiazepines from Nitrooximes, May-Jun. 1983, pp. 551-558.
Shridhar, D.R., et al., “Synthesis of B-Lactams using a New phosphorylating Agent, Phenyl N-Methyl-N-phenylphosphoramidochloridate”, Communications, Oct. 1984, pp. 846-847.
Antilla, J.C., et al., “Copper-Catalyzed Coupling of Arylboronic Acids and Amines,” Organic Letters, 2001, vol. 3, nol. 13, pp. 2077-2079.
Ogawa, Y., et al., “Molecular Cloning of a Non-Isopeptide-Selective Human Endothelin Receptor,” Biochemical and Biophysical Research Communications, vol. 178, No. 1, Jul. 1991, pp. 248-255.
Ohlstein, E.H., et al., “Endothelin-1 Modulates Vascular Smooth Muscle Structure and Vasomotion: Implications in Cardiovascular Pathology,” Drug Development Research 29, 1993, pp. 108-128.
McMillen, M.A., et al., “Endothelins: Polyfunctional Cytokines,” Collective Review, Journal of the American College of Surgeons, May 1995, vol. 180, pp. 621-637.
Trybulski, E.J., et al., “2-Benzazepines. 9.1 Synthesis and Chemistry of 3H-2-Benzazepine and Pyrimido[4,5-d][2]benzazepine Derivatives,” Journal of Organic Chemistry, Jun. 1986, vol. 51, No. 12, pp. 2191-2202.
Trybulski, E.J., et al., “2-Benzazepines. 1.1 Synthesis of 2-Benzazepine-4-ones and 5-ones via 2-Acetylenic Benzophenones,” Journal of Organic Chemistry, Jun. 1982, vol. 47, No. 12, pp. 2441-2447.
Trybulski, E.J., et al., “2-Benzazepines. 9.1 Synthesis and Chemistry of 3H-2-Benzazepine and Pyrimido[4,5-d][2]benzazepine Derivatives,” Journal of Organic Chemistry,Jun. 1986, vol. 51, No. 12, pp. 2191-2202.
Amin, S.G., et al., “A Convenient Method for the Synthesis of B-Lactams via 1-Methyl-2-halopyridinium Salts,” Communications, Mar. 1979, pp. 210-213.
Shridhar, D.R., et al., “A Convenient Annelation of Imines to a-Substituted B-Lactams,” Communications, Jan. 1982, pp. 63-65.
Merifield, E., et al., “Total synthesis of cytochalasin D: total synthesis and full structural assignment of cytochalsin O,” J. Chem. So., 1999, pp. 3269-3283.
Ueda, T., et al., “Nucleosides. XVII. Pyrimidinyl Amino Acids,” Nov. 1963, pp. 697-701.
Koppel H.C., “Pyrimidines. X. (Antibiotics.II) Synthesis of Bacimethrin, 2-Methoxy Analog of Thamine, and Related Alkoxypyridmides,” Midwest Research Institute, vol. 27, May 1962, pp. 3614-3617.
Trybulski, E.J., et al., “2-Benzazepines. 5.1,2 Synthesis of Pyrimido[5,4-d][2]benzazepines and Their Evaluation as Anxiolytic Agents,” J.Med.Chem., 1983, pp. 1589-1596.
Gall, M. et al., “Synthesis of Aminoalkyl-Substituted Imidazo[1,2-a]- and Imidazo [1,5-a]benzodiazepines,” J. Org. Chem, 1981, pp. 1575-1585.
Gilman, N.W., et al., “Atropisomers of 1,4-Benzodiazepines. 2. Synthesis and Resolution of Imidazo[1,5-a][1,4]Benzodiazepines,” J. Org. Chem., 1993, pp. 3285-3298.
Clader, J.W., et al., “2-Azetidinone Cholesterol Absorption Inhibitors: Structure-Activity Relationships on the Heterocyclic Nucleus,” J.Med.Chem., 1996, pp. 3684-3693.
Fryer, R.I., et al., “Quinazolines and 1,4-Benzodiazepines. LXXIII. The Ring Expansion of 2-Chloromethylquinazoline 3-Oxides with Nitromethane,” Jun. 1976, pp. 433-437.
Breslin, H.J., et al., “Synthesis and Anti-HIV-1 Activity of 4,5,6,7-Tetrahydro-5-methylimidazo-[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) Derivatives. 3,” J.Med.Chem., 1995, pp. 771-793.
Sternbach, L.H., et al., “Quinazolines and 1,4-Benzodiazepines. XI. Synthesis and Transformations of 7-Choloro-2-3-dihydro(and 2,32,4,5-tetrahydro)-5-phenyl-1H-1,4-benzodiazepine,” Notes, vol. 28, Mar. 1963, pp. 2456-2459.
Qui, J., et al., “2,6-Difluorophenol as a Bioisostere of a Carboxylic Acid: Bioisosteric Analogues of y-Aminobutyric Acid,” J. Med.Chem., 1999, pp. 329-332.
Trybulski, E.J., et al., “2-Benzazepines. 6.1,2 Synthesis and Pharmacological Properties of the Metabolites of 9-Chloro-7-(2-chloropheny)-5H-pyrimido[5,4-d][p2]benzazepin,” J.Med.Chem., 1983, pp. 1596-1601.
Hester, J.B., et al., “6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine Which Have Central Nervous System Depressant Activity,” Journal of Medicinal Chemistry, 1971, vol. 14, No. 11, pp. 1078-1081.
Walser, A., et al., “Quinazolines and 1,4-Benzodiazepines. 84.1 Synthesis and Reactions of Imidazo[1,5-a][1.4] benzodiazepines,” J.Org.Chem., vol. 43, No. 5, 1978, pp. 936-944.
Rubanyi, G.M., et al., “Endothelins: Molecular Biology, Biochemistry, Pharmacology, Physiology, and Pathophysiology,” Pharmacological Review, vol. 46, No. 3, 1994, pp. 325-415.
Yanagisawa, M., et al., “A novel potent vasoconstrictor peptide produced by vascular endothelial cells,” Nature, vol. 332, Mar. 1988, pp. 411-415.
Umemiya H., et al., “Regulation of Retinoidal Actions by Diazepinylbenzoic Acids. Retinoid Synergists Which Activate the RXR-RAR Heterodimers,” J.Med.Chem., 1997, pp. 4222-4234.
Sakurai, T., et al., “Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor,” Nature, vol. 348, Dec. 1990, pp. 732-735.
Sharma, S.D., et al., “Studies on fuse B-lactams: Synthesis sterochemistry and antimicrobial activity of some new cepham analogues,” Indian Journal of Chemistry, vol. 39B, Feb. 2000, pp. 156-159.
Arai, H., et al., “Cloning and expression of a cDNA endoing an endothelin receptor,” Nature, vol. 348, Dec. 1990, pp. 730-732.
Miyake, M., et al., Synthessis of B-Lactams by Convenient Annelation of Imines, Synthetic Communications, vol. 14(4), 1984, pp. 353-362.
Sumner, M.J., et al., “Endothelin ETa and ETb receptors mediate vascular smooth muscle contraction, ”Br. J. Pharmacol, 1992, pp. 858-860.
Martin, N.H., “75. Synthesis and Photo-oxygenation of Some Substituted 1-Benzyl-3,4-dihydroisoquinolines. Mechanisms of Enamine Photo-oxygenation,” Helvetica Chimca Acta, vol. 65, 1982, pp. 762-774.
Hubschwelen, C., “218. An Enantioselective B-Lactam Synthesis Starting from L-(S)-Glyceraldehyde Acetonide,” Helvetica Chimica Acta, vol. 66, 1983, pp. 2206-2209.
Bremner, J.B., et al., “Synthesis of 5-Aryl-1,4-benzoxazepine and 6-Phenyl-2H-1,5-benzoxazocine Derivative,” Aust.J.Chem, 1984, pp. 129-141.
Brown, D.J., et al., “Isomerizations Akin to the Dimroth Rearrangement. III★The Conversion of Simple s-Triazolo[4,3-a]pyrimidines into Their [1,5-a] Isomers,” Aust. J. Chem. 1997, pp. 2515-2525.
Walser, A., et al., “Quinazolines and 1,4-Benzodiazepines, XCV [1]. Synthesis of 1,4-Benzodiazepines by Ring Expansion of 2-Chloromethylquinazolines with Carbanions,” 1986, pp. 1303-1314.
Fryer, R.I., et al., “Synthesis of Novel, Substituted 4H-Imidazo[1,5-a][1,4]benzodiazepines,” Nov. 1991, pp. 1661-1669.
Manhas, M.S., et al., “Heterocyclic Compounds. X. Bis(2-c
Bolli Martin
Boss Christoph
Clozel Martine
Fischli Walter
Marfurt Judith
Actelion Pharmaceuticals Ltd.
Dickstein & Shapiro LLP
Kifle Bruck
LandOfFree
Benzo-fused heterocycles as endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzo-fused heterocycles as endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzo-fused heterocycles as endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3778083